Monday, July 22, 2024

Latigo Biotherapeutics Names New CEO

Thousand Oaks-based Latigo Biotherapeutics, which is developing non-opioid pain medicines, has named Nima Farzan as its new Chief Executive Officer. Frazan was previously CEO of Kinnate Biopharma, and also was at PaxVax, among other companies. Farzan replaces Desmond Padhi, who was serving as interim CEO; Padhi is the operating partner at Westlake Village BioPartners.